It is well established that chronic hemolysis in SCD leads to increased free heme levels and inflammation [1,2], whereas Nrf2 activators such as DMF have been shown to alleviate inflammatory and oxidative stress [61]. This evidence concerns the gene NFE2L2 and Schnyder corneal dystrophy.